1-1 of 1
Thales Dalessandro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and associated with high response rates.

Clinical Trials & Observations
Ana Rita BM da Fonseca, Caio Cesar Justino, Vinicius Campos de Molla, Patricia Eiko Yamakawa, Iara Baldim Rabelo, Louise M Arnold, Richard J Kelly, Morag Griffin, Talha Munir, Anita Hill, Elvira D R P Velloso, Thales Dalessandro, Antonio Maria Risitano, Phillip Scheinberg, Austin G Kulasekararaj, Celso Arrais-Rodrigues
Journal: Blood Advances
Blood Adv bloodadvances.2024014159.
https://doi.org/10.1182/bloodadvances.2024014159
Published: 2024